Company Data
REGENXBIO Inc.
Ticker
RGNX
Current Price
$7.27 -1.22%
Market Cap
$360.2M
Price Target
Refer to Report
Volume
632.9K
52wk Range
$6.56 - $28.8
Overview
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).